OCU-110

N/A

Report date: 2025/08/08 20:01:41
NME

Base Information

Drug NameOCU-110
Drug Alias NameOCU-110OCU-10-C-110OGX-110
ClassificationSmall molecules
Mechanisms of ActionC-X-C motif chemokine receptor 3 agonists
TargetsC-X-C motif chemokine receptor 3
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesOcugenix Corp
China Registration ClassN/A

Develop Information

Active CompaniesOcugenix Corp
Inactive CompaniesN/A
Active IndicationsMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A